Triumvera, co-founded by McMaster's professor Jonathan Bramson, looks to progress its solid tumour therapeutic candidate.

UC Berkeley spinout SiFive has fetched a $2.5bn valuation in a series F round that pushed its overall financing to more than $350m.

Cowen Healthcare Investments has led a funding round for Scipher Medicine, co-founded by Harvard Medical School colleagues Joseph Loscalzo and Albert-László Barabási.

EPFL spinout MindMaze has raised $105m from investors including AlbaCore Capital, which had supplied $125m in capital only four months ago.

Harvard’s serial entrepreneur Timothy Springer has formally launched his latest venture with a $101m series A round backed by GV.

Scandit has welcomed back shareholders including GV, Schneider Electric, Sony and Swisscom for a round that made the ETH Zurich spinout a unicorn.

MIT spinout Superpedestrian has collected $125m in a series C round that attracted Sony Innovation Fund and Citi Impact Fund.

Ohio Innovation Fund was among the shareholders who returned for Enable Injections’ latest round.

Advancing foundational research from UCLA and Migal – Galilee Research Institute, ImmPact is working on T-cell therapies for liquid and solid cancers.

UCL spinout Ori Biotech has raised more than $100m in a series B round led by Novalis LifeSciences, just over a year after closing a $30m series A round.